Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Syndrome (CIS)”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Post-approval studies (Phase 4)Study completedNCT04998851
What this trial is testing

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Hoffmann-La Roche 26
Testing effectiveness (Phase 2)Study completedNCT00094172
What this trial is testing

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 82
Not applicableStudy completedNCT03692975
What this trial is testing

MRI Hippocampal Microstructure and Episodic Memory in Early Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Bordeaux 84
Large-scale testing (Phase 3)Study completedNCT00287079
What this trial is testing

A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated Syndrome
Merck KGaA, Darmstadt, Germany 35
Testing effectiveness (Phase 2)Study completedNCT00245622
What this trial is testing

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Opexa Therapeutics, Inc. 150
Large-scale testing (Phase 3)Study completedNCT01167426
What this trial is testing

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 148
Not applicableStudy completedNCT03541226
What this trial is testing

Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University Hospital, Lille 134
Testing effectiveness (Phase 2)Ended earlyNCT00624468
What this trial is testing

Atacicept in Subjects With Optic Neuritis

Who this might be right for
Optic Neuritis
EMD Serono 34
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Not applicableLooking for participantsNCT05010902
What this trial is testing

Pregnancy Cohort in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis (MS)Clinically Isolated Syndrome (CIS)
Charite University, Berlin, Germany 100
Not applicableStudy completedNCT03451955
What this trial is testing

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Who this might be right for
Optic NeuritisMultiple SclerosisClinically Isolated Syndrome
University of Copenhagen 103
Not applicableStudy completedNCT00787657
What this trial is testing

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Bayer 1,723
Not applicableEnded earlyNCT00819897
What this trial is testing

Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta

Who this might be right for
Clinically Isolated Syndrome
Centre Hospitalier Universitaire de Nice 37
Not applicableEnded earlyNCT04599023
What this trial is testing

Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Insel Gruppe AG, University Hospital Bern 182
Not applicableStudy completedNCT02308579
What this trial is testing

Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases

Who this might be right for
Clinically Isolated Syndrome (CIS)Multiple Sclerosis (MS)Other Neurological Disorders (OND)+1 more
University at Buffalo 499
Not applicableStudy completedNCT01804647
What this trial is testing

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease

Who this might be right for
Multiple Sclerosis (MS)Relapsing-Remitting MSPrimary Progressive MS+2 more
GeNeuro Innovation SAS 58
Early research (Phase 1)Study completedNCT01031199
What this trial is testing

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Who this might be right for
Positron-Emission TomographyMultiple Sclerosis
Bayer 16
Not applicableEnrolling By InvitationNCT07183020
What this trial is testing

Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome (CIS)
Skripuletz, Thomas Prof. Dr. 1,142
Testing effectiveness (Phase 2)Ended earlyNCT01039103
What this trial is testing

Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Acute Exacerbation of Remitting Relapsing Multiple SclerosisClinically Isolated Syndrome
Galapagos NV 15
Post-approval studies (Phase 4)UnknownNCT00910598
What this trial is testing

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Amphia Hospital 60
Load More Results